SHA:600165 Revenue

In the year 2025, Ningxia Zhongke Biotechnology had annual revenue of 444.48M CNY with 28.72% growth. Ningxia Zhongke Biotechnology had revenue of 117.13M in the quarter ending December 31, 2025, a decrease of -27.15%.

Revenue

444.48M

Revenue Growth

+28.72%

P/S Ratio

12.58

Revenue / Employee

532.95K

Employees

834

Market Cap

5.59B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	444.48M	99.16M	28.72%
Dec 31, 2024	345.32M	59.63M	20.87%
Dec 31, 2023	285.69M	-395.44M	-58.06%
Dec 31, 2022	681.13M	432.42M	173.86%
Dec 31, 2021	248.72M	129.60M	108.80%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hanvo Safety Product	1.22B
Shanxi Huhua Group	1.31B
Shenzhen WOTE Advanced Materials Co.,Ltd	2.05B
Sokan New Materials Group	694.76M
Cybrid Technologies	2.74B
Anshan Hifichem	1.53B
Jiangsu Boiln Plastics	523.45M
Shandong Link Science and Technology	2.31B

Revenue Rankings